Arcturus Therapeutics Holdings Inc.
ARCT· Nasdaq
Released Aug 6, 2026, after the close
10-Q filed Aug 6, 2026, 37 days after period end · 0001193125-26-338090
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $2.96M | $28.30M | $49.86M | $10.52M |
| Net Income | -$23.79M | -$9.18M | -$17.22M | -$52.55M |
| EPS Diluted |
Arcturus Therapeutics Holdings Inc. · CIK 1768224 · Engraved from SEC EDGAR
| -$0.84 |
| -$0.34 |
| -$0.64 |
| -$1.98 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.